Legato Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Hold |
42,146
| – | – | 0.23% | 120 |
|
|
2025
Q1 | $2.57M | Hold |
42,146
| – | – | 0.35% | 69 |
|
|
2024
Q4 | $2.38M | Hold |
42,146
| – | – | 0.31% | 75 |
|
|
2024
Q3 | $2.18M | Buy |
42,146
+5,889
| +16% | +$305K | 0.27% | 106 |
|
|
2024
Q2 | $1.51M | Sell |
36,257
-16,614
| -31% | -$690K | 0.2% | 177 |
|
|
2024
Q1 | $2.87M | Buy |
52,871
+9,298
| +21% | +$504K | 0.35% | 70 |
|
|
2023
Q4 | $2.24M | Hold |
43,573
| – | – | 0.29% | 97 |
|
|
2023
Q3 | $2.53M | Hold |
43,573
| – | – | 0.37% | 56 |
|
|
2023
Q2 | $2.79M | Buy |
43,573
+6,568
| +18% | +$420K | 0.38% | 59 |
|
|
2023
Q1 | $2.56M | Buy |
37,005
+4,751
| +15% | +$329K | 0.47% | 39 |
|
|
2022
Q4 | $2.32M | Buy |
+32,254
| New | +$2.32M | 0.44% | 42 |
|